While generally safe for most people, a thorough consultation is necessary to determine if the treatment suits you based on your health history and goals
(PubMed) Garone C, Donati MA, Sacchini M, et al
No completed randomized controlled human trials exist for any indication as of 2026
Wegovy tablets and injections are FDA-approved in adults for: weight loss and weight management in adults with obesity or adults who are overweight and have a weight-related medical problem (e.g., blood pressure, type 2 diabetes, or high cholesterol) reducing major cardiovascular event risks (such as heart attack, stroke, or death) in adults with established CV disease and either obesity or overweight Wegovy injection is also FDA-approved for: weight loss and weight management patients with obesity who are 12 years and older non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), this is an accelerated approval
Dietary prebiotics alter novel microbial dependent fecal metabolites that improve sleep
To address these issues, researchers must develop unified data standards and establish shared platforms to enhance data interoperability and reproducibility